Rank | Gene Set | Z-score |
---|---|---|
1 | desmosome organization (GO:0002934) | 5.02463235 |
2 | establishment of skin barrier (GO:0061436) | 4.89186503 |
3 | hypotonic response (GO:0006971) | 4.76848349 |
4 | regulation of water loss via skin (GO:0033561) | 4.66888674 |
5 | COPI coating of Golgi vesicle (GO:0048205) | 4.05103356 |
6 | Golgi transport vesicle coating (GO:0048200) | 4.05103356 |
7 | nuclear pore complex assembly (GO:0051292) | 4.01353602 |
8 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.93474413 |
9 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.88115780 |
10 | regulation of pigment cell differentiation (GO:0050932) | 3.86293750 |
11 | peptidyl-threonine dephosphorylation (GO:0035970) | 3.68511815 |
12 | mesodermal cell differentiation (GO:0048333) | 3.65363290 |
13 | mammary gland epithelial cell proliferation (GO:0033598) | 3.57096101 |
14 | phospholipid efflux (GO:0033700) | 3.51152911 |
15 | hemidesmosome assembly (GO:0031581) | 3.47828337 |
16 | intestinal cholesterol absorption (GO:0030299) | 3.39267612 |
17 | embryonic process involved in female pregnancy (GO:0060136) | 3.32657750 |
18 | multicellular organismal water homeostasis (GO:0050891) | 3.28601521 |
19 | nuclear pore organization (GO:0006999) | 3.24669266 |
20 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.20558079 |
21 | cell-substrate junction assembly (GO:0007044) | 3.20019357 |
22 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 3.19538811 |
23 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.17264429 |
24 | positive regulation of osteoblast proliferation (GO:0033690) | 3.11145957 |
25 | regulation of phospholipase A2 activity (GO:0032429) | 3.10948100 |
26 | activation of Rac GTPase activity (GO:0032863) | 3.05071046 |
27 | barbed-end actin filament capping (GO:0051016) | 3.04081575 |
28 | water homeostasis (GO:0030104) | 3.00166352 |
29 | positive regulation of p38MAPK cascade (GO:1900745) | 2.99385870 |
30 | positive regulation of cholesterol efflux (GO:0010875) | 2.96506461 |
31 | regulation of cholesterol homeostasis (GO:2000188) | 2.96488654 |
32 | COPII vesicle coating (GO:0048208) | 2.89971781 |
33 | positive regulation of developmental pigmentation (GO:0048087) | 2.88351862 |
34 | positive regulation of sterol transport (GO:0032373) | 2.88153226 |
35 | positive regulation of cholesterol transport (GO:0032376) | 2.88153226 |
36 | keratinization (GO:0031424) | 2.87550514 |
37 | gap junction assembly (GO:0016264) | 2.87356606 |
38 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.84882363 |
39 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.84497578 |
40 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.83012425 |
41 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.82571621 |
42 | low-density lipoprotein particle clearance (GO:0034383) | 2.81998739 |
43 | negative regulation of anoikis (GO:2000811) | 2.81644524 |
44 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.80277140 |
45 | negative regulation of DNA repair (GO:0045738) | 2.79976936 |
46 | pore complex assembly (GO:0046931) | 2.75577491 |
47 | modulation by symbiont of host immune response (GO:0052553) | 2.75276406 |
48 | positive regulation by symbiont of host defense response (GO:0052509) | 2.75276406 |
49 | modulation by symbiont of host defense response (GO:0052031) | 2.75276406 |
50 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.75276406 |
51 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.75276406 |
52 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.75276406 |
53 | surfactant homeostasis (GO:0043129) | 2.73909366 |
54 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.73672971 |
55 | protein carboxylation (GO:0018214) | 2.73672971 |
56 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.72602901 |
57 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.71075386 |
58 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.69389095 |
59 | L-phenylalanine catabolic process (GO:0006559) | 2.69389095 |
60 | hormone catabolic process (GO:0042447) | 2.68635964 |
61 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.68439008 |
62 | vesicle coating (GO:0006901) | 2.68145403 |
63 | lung vasculature development (GO:0060426) | 2.66956312 |
64 | glomerular visceral epithelial cell development (GO:0072015) | 2.65953869 |
65 | bone remodeling (GO:0046849) | 2.65917776 |
66 | sulfur amino acid catabolic process (GO:0000098) | 2.64988864 |
67 | keratinocyte differentiation (GO:0030216) | 2.64632740 |
68 | protein hydroxylation (GO:0018126) | 2.64195747 |
69 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.63470105 |
70 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.60583361 |
71 | membrane raft organization (GO:0031579) | 2.58470573 |
72 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.58446233 |
73 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.58196492 |
74 | endothelial cell morphogenesis (GO:0001886) | 2.58122337 |
75 | alpha-linolenic acid metabolic process (GO:0036109) | 2.57967579 |
76 | regulation of cholesterol storage (GO:0010885) | 2.57923113 |
77 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.57327591 |
78 | negative regulation of fatty acid transport (GO:2000192) | 2.56752213 |
79 | establishment of endothelial barrier (GO:0061028) | 2.55925013 |
80 | growth hormone receptor signaling pathway (GO:0060396) | 2.54169712 |
81 | adherens junction assembly (GO:0034333) | 2.53930534 |
82 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.53826228 |
83 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.52837260 |
84 | skin morphogenesis (GO:0043589) | 2.52165049 |
85 | transcytosis (GO:0045056) | 2.52076751 |
86 | apoptotic cell clearance (GO:0043277) | 2.51311903 |
87 | linoleic acid metabolic process (GO:0043651) | 2.50945542 |
88 | plasma lipoprotein particle clearance (GO:0034381) | 2.50838210 |
89 | epidermal cell differentiation (GO:0009913) | 2.50039395 |
90 | phospholipid homeostasis (GO:0055091) | 2.49431904 |
91 | focal adhesion assembly (GO:0048041) | 2.48115653 |
92 | cell-substrate adherens junction assembly (GO:0007045) | 2.48115653 |
93 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.47670428 |
94 | regulation of anoikis (GO:2000209) | 2.47472595 |
95 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.46894772 |
96 | L-phenylalanine metabolic process (GO:0006558) | 2.46894772 |
97 | cysteine metabolic process (GO:0006534) | 2.46354401 |
98 | SMAD protein complex assembly (GO:0007183) | 2.46229652 |
99 | homocysteine metabolic process (GO:0050667) | 2.46159809 |
100 | chemical homeostasis within a tissue (GO:0048875) | 2.45510850 |
101 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.45376482 |
102 | morphogenesis of an epithelial sheet (GO:0002011) | 2.44596258 |
103 | iron ion import (GO:0097286) | 2.43342891 |
104 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.41993676 |
105 | regulation of RNA export from nucleus (GO:0046831) | 2.41767751 |
106 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 2.40119745 |
107 | mRNA transcription (GO:0009299) | 2.39948795 |
108 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.39616195 |
109 | hippo signaling (GO:0035329) | 2.39494002 |
110 | definitive hemopoiesis (GO:0060216) | 2.39429186 |
111 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.39279067 |
112 | response to methylmercury (GO:0051597) | 2.38965235 |
113 | intestinal absorption (GO:0050892) | 2.38939911 |
114 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.38692869 |
115 | embryonic eye morphogenesis (GO:0048048) | 2.38381715 |
116 | cellular senescence (GO:0090398) | 2.37840942 |
117 | protein localization to microtubule (GO:0035372) | 2.37637745 |
118 | negative regulation of lipase activity (GO:0060192) | 2.37451851 |
119 | fibrinolysis (GO:0042730) | 2.35941483 |
120 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.35806216 |
121 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.35416353 |
122 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.34951171 |
123 | detection of bacterium (GO:0016045) | 2.34321060 |
124 | positive regulation of lipid catabolic process (GO:0050996) | 2.34309088 |
125 | epithelial cell-cell adhesion (GO:0090136) | 2.34306111 |
126 | urea metabolic process (GO:0019627) | 2.33573349 |
127 | urea cycle (GO:0000050) | 2.33573349 |
128 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.33009583 |
129 | endodermal cell differentiation (GO:0035987) | 2.32914304 |
130 | protein localization to endosome (GO:0036010) | 2.32717081 |
131 | reverse cholesterol transport (GO:0043691) | 2.32071482 |
132 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.31755055 |
133 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.31551039 |
134 | regulation of glomerular filtration (GO:0003093) | 2.31300606 |
135 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.30714899 |
136 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.30558287 |
137 | positive regulation of establishment of protein localization to plasma membrane (GO:0090004) | 2.30049887 |
138 | high-density lipoprotein particle remodeling (GO:0034375) | 2.29724295 |
139 | detection of other organism (GO:0098543) | 2.29570415 |
140 | positive regulation of extracellular matrix organization (GO:1903055) | 2.28998305 |
141 | plasma membrane repair (GO:0001778) | 2.28896002 |
142 | regulation of p38MAPK cascade (GO:1900744) | 2.28788311 |
143 | regulation of keratinocyte differentiation (GO:0045616) | 2.28778662 |
144 | regulation of triglyceride catabolic process (GO:0010896) | 2.28724085 |
145 | response to laminar fluid shear stress (GO:0034616) | 2.28547009 |
146 | endocardial cushion development (GO:0003197) | 2.28536601 |
147 | regulation of mitotic spindle organization (GO:0060236) | 2.28408066 |
148 | positive regulation of receptor recycling (GO:0001921) | 2.27426745 |
149 | stress fiber assembly (GO:0043149) | 2.26899564 |
150 | glomerular epithelial cell development (GO:0072310) | 2.26579608 |
151 | adhesion of symbiont to host cell (GO:0044650) | 2.26466203 |
152 | virion attachment to host cell (GO:0019062) | 2.26466203 |
153 | complement activation, alternative pathway (GO:0006957) | 2.26277420 |
154 | amino-acid betaine metabolic process (GO:0006577) | 2.25956350 |
155 | chondrocyte proliferation (GO:0035988) | 2.24862996 |
156 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.24414233 |
157 | aromatic amino acid family catabolic process (GO:0009074) | 2.24245085 |
158 | cell-cell junction assembly (GO:0007043) | 2.23595727 |
159 | cellular modified amino acid catabolic process (GO:0042219) | 2.22882085 |
160 | regulation of protein localization to plasma membrane (GO:1903076) | 2.22874774 |
161 | protein retention in ER lumen (GO:0006621) | 2.22273276 |
162 | regulation of early endosome to late endosome transport (GO:2000641) | 2.22016289 |
163 | cell adhesion mediated by integrin (GO:0033627) | 2.21846840 |
164 | regulation of cholesterol transport (GO:0032374) | 2.21729070 |
165 | regulation of sterol transport (GO:0032371) | 2.21729070 |
166 | macrophage activation involved in immune response (GO:0002281) | 2.21491782 |
167 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.20941110 |
168 | valine metabolic process (GO:0006573) | 2.20806371 |
169 | cholesterol efflux (GO:0033344) | 2.20532384 |
170 | negative regulation of lipid storage (GO:0010888) | 2.20229098 |
171 | sphingosine metabolic process (GO:0006670) | 2.20024266 |
172 | cholesterol transport (GO:0030301) | 2.18411946 |
173 | sterol transport (GO:0015918) | 2.18411946 |
174 | negative regulation of cholesterol transport (GO:0032375) | 2.18297665 |
175 | negative regulation of sterol transport (GO:0032372) | 2.18297665 |
176 | keratinocyte proliferation (GO:0043616) | 2.18142575 |
177 | lysine catabolic process (GO:0006554) | 2.17764852 |
178 | lysine metabolic process (GO:0006553) | 2.17764852 |
179 | lipoprotein metabolic process (GO:0042157) | 2.16919618 |
180 | T-helper 1 type immune response (GO:0042088) | 2.13809571 |
181 | regulation of cholesterol efflux (GO:0010874) | 2.12149581 |
182 | cellular response to growth hormone stimulus (GO:0071378) | 2.12012309 |
183 | positive regulation of interferon-alpha production (GO:0032727) | 2.11928575 |
184 | primary alcohol catabolic process (GO:0034310) | 2.10411079 |
185 | macroautophagy (GO:0016236) | 2.09307378 |
186 | adhesion of symbiont to host (GO:0044406) | 2.08770397 |
187 | bile acid biosynthetic process (GO:0006699) | 2.06619427 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.76095560 |
2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.04761293 |
3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.73655284 |
4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.35549374 |
5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.03632873 |
6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.91838441 |
7 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.89138779 |
8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.76942369 |
9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.75119760 |
10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.42466769 |
11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.34887880 |
12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.20333855 |
13 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.13487505 |
14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.10518662 |
15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.09202474 |
16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.06550179 |
17 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 2.05927317 |
18 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.03490003 |
19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.90703708 |
20 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.86981629 |
21 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.84541702 |
22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.81482331 |
23 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.80846341 |
24 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.80178369 |
25 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.73256500 |
26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.73128675 |
27 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.71158360 |
28 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.70496100 |
29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.69804849 |
30 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.69365924 |
31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.68743775 |
32 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.61441880 |
33 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.60726637 |
34 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.60235328 |
35 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.58851110 |
36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.58555501 |
37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.57669376 |
38 | ATF3_27146783_Chip-Seq_COLON_Human | 1.57364791 |
39 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.55681769 |
40 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.50667692 |
41 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.50615254 |
42 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48705952 |
43 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.48520572 |
44 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.47249274 |
45 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.46008803 |
46 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.45554988 |
47 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.45509343 |
48 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.44090670 |
49 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.43086399 |
50 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.42750194 |
51 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.42042333 |
52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.40287542 |
53 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.40072320 |
54 | GATA1_22025678_ChIP-Seq_K562_Human | 1.38027732 |
55 | CJUN_26792858_Chip-Seq_BT549_Human | 1.37066441 |
56 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.35495635 |
57 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35269386 |
58 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35191151 |
59 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.35098889 |
60 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.34903010 |
61 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.34782982 |
62 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.34782982 |
63 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.33847874 |
64 | TP53_16413492_ChIP-PET_HCT116_Human | 1.32694926 |
65 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.30584327 |
66 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.29969849 |
67 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.29439525 |
68 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.25619142 |
69 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25415244 |
70 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.24488820 |
71 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23465021 |
72 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.23246802 |
73 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.21833456 |
74 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.20702145 |
75 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19140707 |
76 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.18783864 |
77 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.18451891 |
78 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.17075295 |
79 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.17075295 |
80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.15201053 |
81 | RXR_22108803_ChIP-Seq_LS180_Human | 1.14895416 |
82 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.14634103 |
83 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13977532 |
84 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.13941418 |
85 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.12238940 |
86 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10436330 |
87 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.09429015 |
88 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.08522133 |
89 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.08071735 |
90 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06541798 |
91 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.05422466 |
92 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.05264128 |
93 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05193203 |
94 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.04046778 |
95 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03955645 |
96 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02026002 |
97 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01541160 |
98 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99641805 |
99 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.98982943 |
100 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.96774309 |
101 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.96100706 |
102 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95607228 |
103 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.94407581 |
104 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.94163378 |
105 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94053698 |
106 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.93172941 |
107 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.92738568 |
108 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.92738568 |
109 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.92521758 |
110 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.92362264 |
111 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91817097 |
112 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.91593696 |
113 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90477303 |
114 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90118140 |
115 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.89483494 |
116 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.89103923 |
117 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.88701872 |
118 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86564224 |
119 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.86313635 |
120 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.85827195 |
121 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84581863 |
122 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.84443185 |
123 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84353785 |
124 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.82301549 |
125 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.81924872 |
126 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80128216 |
127 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.79542796 |
128 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.79287940 |
129 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.79164450 |
130 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.79060818 |
131 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78997689 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0010234_abnormal_vibrissa_follicle | 4.27663521 |
2 | MP0002796_impaired_skin_barrier | 4.21923378 |
3 | MP0002254_reproductive_system_inflammat | 3.19211335 |
4 | MP0003191_abnormal_cellular_cholesterol | 3.16334359 |
5 | MP0005275_abnormal_skin_tensile | 3.13054411 |
6 | MP0005360_urolithiasis | 3.08502241 |
7 | MP0003705_abnormal_hypodermis_morpholog | 2.85434624 |
8 | MP0002139_abnormal_hepatobiliary_system | 2.77661635 |
9 | MP0003941_abnormal_skin_development | 2.67325505 |
10 | MP0005365_abnormal_bile_salt | 2.59139536 |
11 | MP0005085_abnormal_gallbladder_physiolo | 2.51869269 |
12 | MP0001666_abnormal_nutrient_absorption | 2.45859737 |
13 | MP0005409_darkened_coat_color | 2.44444928 |
14 | MP0004947_skin_inflammation | 2.37522960 |
15 | MP0005501_abnormal_skin_physiology | 2.35389115 |
16 | MP0002060_abnormal_skin_morphology | 2.23752649 |
17 | MP0003453_abnormal_keratinocyte_physiol | 2.13871790 |
18 | MP0005257_abnormal_intraocular_pressure | 2.12455071 |
19 | MP0005451_abnormal_body_composition | 2.06892612 |
20 | MP0003300_gastrointestinal_ulcer | 1.95818074 |
21 | MP0003252_abnormal_bile_duct | 1.95584335 |
22 | MP0010678_abnormal_skin_adnexa | 1.94948825 |
23 | MP0009780_abnormal_chondrocyte_physiolo | 1.94699004 |
24 | MP0003566_abnormal_cell_adhesion | 1.91462616 |
25 | MP0001216_abnormal_epidermal_layer | 1.91322575 |
26 | MP0005083_abnormal_biliary_tract | 1.89483658 |
27 | MP0003828_pulmonary_edema | 1.85573522 |
28 | MP0008875_abnormal_xenobiotic_pharmacok | 1.82609579 |
29 | MP0009840_abnormal_foam_cell | 1.82261919 |
30 | MP0005058_abnormal_lysosome_morphology | 1.71846073 |
31 | MP0000579_abnormal_nail_morphology | 1.61056428 |
32 | MP0010329_abnormal_lipoprotein_level | 1.56075895 |
33 | MP0003950_abnormal_plasma_membrane | 1.54875755 |
34 | MP0000383_abnormal_hair_follicle | 1.53598262 |
35 | MP0009697_abnormal_copulation | 1.53345849 |
36 | MP0003436_decreased_susceptibility_to | 1.51851325 |
37 | MP0002098_abnormal_vibrissa_morphology | 1.50886901 |
38 | MP0002138_abnormal_hepatobiliary_system | 1.45692139 |
39 | MP0010771_integument_phenotype | 1.45638139 |
40 | MP0004019_abnormal_vitamin_homeostasis | 1.42654757 |
41 | MP0000762_abnormal_tongue_morphology | 1.41066688 |
42 | MP0004233_abnormal_muscle_weight | 1.40864422 |
43 | MP0005248_abnormal_Harderian_gland | 1.38330397 |
44 | MP0002896_abnormal_bone_mineralization | 1.34151295 |
45 | MP0000377_abnormal_hair_follicle | 1.29703470 |
46 | MP0000647_abnormal_sebaceous_gland | 1.28784830 |
47 | MP0002877_abnormal_melanocyte_morpholog | 1.25200708 |
48 | MP0000537_abnormal_urethra_morphology | 1.24886824 |
49 | MP0004381_abnormal_hair_follicle | 1.24557981 |
50 | MP0003303_peritoneal_inflammation | 1.24447537 |
51 | MP0000733_abnormal_muscle_development | 1.24205741 |
52 | MP0006138_congestive_heart_failure | 1.23569826 |
53 | MP0001915_intracranial_hemorrhage | 1.23327101 |
54 | MP0002166_altered_tumor_susceptibility | 1.20675275 |
55 | MP0003279_aneurysm | 1.20041575 |
56 | MP0004808_abnormal_hematopoietic_stem | 1.19562812 |
57 | MP0003195_calcinosis | 1.18952257 |
58 | MP0005076_abnormal_cell_differentiation | 1.16568867 |
59 | * MP0002118_abnormal_lipid_homeostasis | 1.15074261 |
60 | MP0008438_abnormal_cutaneous_collagen | 1.14681489 |
61 | MP0005623_abnormal_meninges_morphology | 1.14508270 |
62 | MP0002009_preneoplasia | 1.13602303 |
63 | MP0009053_abnormal_anal_canal | 1.11863487 |
64 | * MP0000609_abnormal_liver_physiology | 1.11555496 |
65 | MP0005164_abnormal_response_to | 1.10365689 |
66 | MP0001191_abnormal_skin_condition | 1.10364417 |
67 | MP0009931_abnormal_skin_appearance | 1.09865675 |
68 | MP0009643_abnormal_urine_homeostasis | 1.08929997 |
69 | MP0003724_increased_susceptibility_to | 1.08017692 |
70 | MP0001879_abnormal_lymphatic_vessel | 1.06352542 |
71 | MP0005332_abnormal_amino_acid | 1.04978126 |
72 | MP0000604_amyloidosis | 1.04544521 |
73 | MP0002006_tumorigenesis | 1.03828642 |
74 | MP0000767_abnormal_smooth_muscle | 1.03571028 |
75 | MP0008057_abnormal_DNA_replication | 1.03063168 |
76 | MP0010352_gastrointestinal_tract_polyps | 1.01831804 |
77 | MP0002086_abnormal_extraembryonic_tissu | 1.01435992 |
78 | MP0003075_altered_response_to | 1.01342434 |
79 | MP0005621_abnormal_cell_physiology | 1.01067167 |
80 | MP0004272_abnormal_basement_membrane | 1.00161836 |
81 | MP0004264_abnormal_extraembryonic_tissu | 1.00101623 |
82 | MP0004782_abnormal_surfactant_physiolog | 0.99617574 |
83 | MP0005167_abnormal_blood-brain_barrier | 0.99364291 |
84 | MP0000427_abnormal_hair_cycle | 0.99259386 |
85 | MP0009764_decreased_sensitivity_to | 0.99077451 |
86 | MP0000013_abnormal_adipose_tissue | 0.98856825 |
87 | MP0006082_CNS_inflammation | 0.98277872 |
88 | MP0003868_abnormal_feces_composition | 0.96592217 |
89 | MP0001533_abnormal_skeleton_physiology | 0.96081566 |
90 | MP0000627_abnormal_mammary_gland | 0.94848791 |
91 | MP0002419_abnormal_innate_immunity | 0.94431547 |
92 | MP0005023_abnormal_wound_healing | 0.94283834 |
93 | MP0001835_abnormal_antigen_presentation | 0.93832954 |
94 | MP0001346_abnormal_lacrimal_gland | 0.91629079 |
95 | MP0003045_fibrosis | 0.91104297 |
96 | MP0005171_absent_coat_pigmentation | 0.90882524 |
97 | MP0003690_abnormal_glial_cell | 0.90097002 |
98 | MP0002998_abnormal_bone_remodeling | 0.89999123 |
99 | MP0000003_abnormal_adipose_tissue | 0.89433104 |
100 | MP0009384_cardiac_valve_regurgitation | 0.89061999 |
101 | MP0002136_abnormal_kidney_physiology | 0.87917546 |
102 | MP0008004_abnormal_stomach_pH | 0.87156663 |
103 | MP0001348_abnormal_lacrimal_gland | 0.86846960 |
104 | MP0002092_abnormal_eye_morphology | 0.86759096 |
105 | MP0001851_eye_inflammation | 0.85808543 |
106 | MP0000367_abnormal_coat/_hair | 0.84789766 |
107 | MP0001243_abnormal_dermal_layer | 0.83462381 |
108 | MP0005464_abnormal_platelet_physiology | 0.83173693 |
109 | MP0004084_abnormal_cardiac_muscle | 0.82231657 |
110 | MP0005503_abnormal_tendon_morphology | 0.81423480 |
111 | MP0001790_abnormal_immune_system | 0.80761161 |
112 | MP0005387_immune_system_phenotype | 0.80761161 |
113 | MP0003385_abnormal_body_wall | 0.80512535 |
114 | MP0000467_abnormal_esophagus_morphology | 0.80200553 |
115 | MP0008469_abnormal_protein_level | 0.80193353 |
116 | MP0002148_abnormal_hypersensitivity_rea | 0.79995236 |
117 | MP0010155_abnormal_intestine_physiology | 0.78578185 |
118 | MP0000569_abnormal_digit_pigmentation | 0.78536324 |
119 | MP0004130_abnormal_muscle_cell | 0.78406949 |
120 | MP0001845_abnormal_inflammatory_respons | 0.77483844 |
121 | MP0004197_abnormal_fetal_growth/weight/ | 0.77105167 |
122 | MP0005000_abnormal_immune_tolerance | 0.77102690 |
123 | MP0001873_stomach_inflammation | 0.76957488 |
124 | MP0005319_abnormal_enzyme/_coenzyme | 0.76064349 |
125 | MP0005165_increased_susceptibility_to | 0.75780686 |
126 | MP0005670_abnormal_white_adipose | 0.75769639 |
127 | MP0005025_abnormal_response_to | 0.75728141 |
128 | MP0010630_abnormal_cardiac_muscle | 0.75165606 |
129 | MP0001756_abnormal_urination | 0.74899674 |
130 | * MP0004185_abnormal_adipocyte_glucose | 0.74208892 |
131 | MP0010368_abnormal_lymphatic_system | 0.73541422 |
132 | MP0000685_abnormal_immune_system | 0.73158791 |
133 | MP0000428_abnormal_craniofacial_morphol | 0.72477418 |
134 | MP0001958_emphysema | 0.72426216 |
135 | MP0003984_embryonic_growth_retardation | 0.72147405 |
136 | MP0000432_abnormal_head_morphology | 0.72086681 |
137 | MP0003172_abnormal_lysosome_physiology | 0.71873967 |
138 | MP0003091_abnormal_cell_migration | 0.71569491 |
139 | MP0003943_abnormal_hepatobiliary_system | 0.71259562 |
140 | MP0002925_abnormal_cardiovascular_devel | 0.71247989 |
141 | MP0003656_abnormal_erythrocyte_physiolo | 0.70129854 |
142 | MP0000465_gastrointestinal_hemorrhage | 0.69845222 |
143 | MP0001849_ear_inflammation | 0.69567377 |
144 | MP0002697_abnormal_eye_size | 0.68164868 |
145 | MP0005197_abnormal_uvea_morphology | 0.68023013 |
146 | MP0005187_abnormal_penis_morphology | 0.67251434 |
147 | MP0004087_abnormal_muscle_fiber | 0.66982868 |
148 | MP0002088_abnormal_embryonic_growth/wei | 0.66112114 |
149 | MP0001614_abnormal_blood_vessel | 0.65863106 |
150 | MP0005193_abnormal_anterior_eye | 0.65428494 |
151 | MP0009379_abnormal_foot_pigmentation | 0.64606353 |
152 | MP0001661_extended_life_span | 0.63833351 |
153 | MP0000858_altered_metastatic_potential | 0.62881679 |
154 | MP0002128_abnormal_blood_circulation | 0.62734184 |
155 | MP0001784_abnormal_fluid_regulation | 0.61822462 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Protrusio acetabuli (HP:0003179) | 3.96554447 |
2 | Eczematoid dermatitis (HP:0000976) | 3.79929785 |
3 | Right ventricular cardiomyopathy (HP:0011663) | 3.69345750 |
4 | Increased IgE level (HP:0003212) | 3.69056694 |
5 | Subacute progressive viral hepatitis (HP:0006572) | 3.44557481 |
6 | Arterial tortuosity (HP:0005116) | 3.41532691 |
7 | Myocardial infarction (HP:0001658) | 3.40773695 |
8 | Xanthomatosis (HP:0000991) | 3.25997031 |
9 | Premature rupture of membranes (HP:0001788) | 3.24272382 |
10 | Vascular tortuosity (HP:0004948) | 3.11875118 |
11 | Deep venous thrombosis (HP:0002625) | 3.06539296 |
12 | Plantar hyperkeratosis (HP:0007556) | 3.03118163 |
13 | Vertebral arch anomaly (HP:0008438) | 2.94349682 |
14 | Ankyloglossia (HP:0010296) | 2.92229522 |
15 | Systemic lupus erythematosus (HP:0002725) | 2.89568858 |
16 | Intrahepatic cholestasis (HP:0001406) | 2.89061009 |
17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.88574448 |
18 | Insomnia (HP:0100785) | 2.84965805 |
19 | Complement deficiency (HP:0004431) | 2.81513795 |
20 | Thick nail (HP:0001805) | 2.79632665 |
21 | Lip pit (HP:0100267) | 2.79238888 |
22 | Abnormality of proline metabolism (HP:0010907) | 2.69981865 |
23 | Hydroxyprolinuria (HP:0003080) | 2.69981865 |
24 | Palmoplantar hyperkeratosis (HP:0000972) | 2.69789755 |
25 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.69454857 |
26 | Spinal cord lesions (HP:0100561) | 2.67921563 |
27 | Syringomyelia (HP:0003396) | 2.67921563 |
28 | Glomerulonephritis (HP:0000099) | 2.65922729 |
29 | Termporal pattern (HP:0011008) | 2.64662132 |
30 | Insidious onset (HP:0003587) | 2.64662132 |
31 | Papillary thyroid carcinoma (HP:0002895) | 2.59161527 |
32 | Vacuolated lymphocytes (HP:0001922) | 2.56487020 |
33 | Mucopolysacchariduria (HP:0008155) | 2.55432948 |
34 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.55432948 |
35 | Increased cerebral lipofuscin (HP:0011813) | 2.54814322 |
36 | Hypotrichosis (HP:0001006) | 2.53951870 |
37 | Short nail (HP:0001799) | 2.53744897 |
38 | Nephritis (HP:0000123) | 2.51097656 |
39 | Abnormality of nail color (HP:0100643) | 2.50596975 |
40 | Palmar hyperkeratosis (HP:0010765) | 2.49827698 |
41 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.48491247 |
42 | Flat acetabular roof (HP:0003180) | 2.47924982 |
43 | Dysostosis multiplex (HP:0000943) | 2.47349177 |
44 | Milia (HP:0001056) | 2.47122062 |
45 | Aortic aneurysm (HP:0004942) | 2.45328993 |
46 | Broad face (HP:0000283) | 2.43623757 |
47 | Axonal loss (HP:0003447) | 2.42965023 |
48 | Esophageal varix (HP:0002040) | 2.41984800 |
49 | Gangrene (HP:0100758) | 2.40272752 |
50 | Abnormality of complement system (HP:0005339) | 2.38344899 |
51 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.37981855 |
52 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.37981855 |
53 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.37981855 |
54 | Abnormality of oral frenula (HP:0000190) | 2.36801315 |
55 | Amyloidosis (HP:0011034) | 2.36271023 |
56 | Aortic dissection (HP:0002647) | 2.36108582 |
57 | Fragile skin (HP:0001030) | 2.34750502 |
58 | Spondylolisthesis (HP:0003302) | 2.34389393 |
59 | Onycholysis (HP:0001806) | 2.34114640 |
60 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.33959446 |
61 | Woolly hair (HP:0002224) | 2.33753559 |
62 | Fat malabsorption (HP:0002630) | 2.33710197 |
63 | Epidermoid cyst (HP:0200040) | 2.30077233 |
64 | Wormian bones (HP:0002645) | 2.29829471 |
65 | Osteolytic defects of the hand bones (HP:0009699) | 2.29621371 |
66 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.29621371 |
67 | Hyporeflexia of lower limbs (HP:0002600) | 2.29595804 |
68 | Abnormality of the common coagulation pathway (HP:0010990) | 2.26569874 |
69 | Hematochezia (HP:0002573) | 2.25862205 |
70 | Hypoalphalipoproteinemia (HP:0003233) | 2.24344128 |
71 | Focal segmental glomerulosclerosis (HP:0000097) | 2.24210998 |
72 | Joint hemorrhage (HP:0005261) | 2.19771553 |
73 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.18342835 |
74 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.16324158 |
75 | Increased connective tissue (HP:0009025) | 2.13854049 |
76 | Atrophic scars (HP:0001075) | 2.13576441 |
77 | Vertebral compression fractures (HP:0002953) | 2.11807146 |
78 | Hyperlipoproteinemia (HP:0010980) | 2.11756833 |
79 | Cerebral aneurysm (HP:0004944) | 2.06161681 |
80 | Micronodular cirrhosis (HP:0001413) | 2.06066443 |
81 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.05678474 |
82 | Subaortic stenosis (HP:0001682) | 2.05678474 |
83 | Hypoglycemic coma (HP:0001325) | 2.05582154 |
84 | Recurrent bacterial skin infections (HP:0005406) | 2.04976638 |
85 | Periodontitis (HP:0000704) | 2.03066539 |
86 | Absent frontal sinuses (HP:0002688) | 2.02830682 |
87 | Hypercholesterolemia (HP:0003124) | 2.02155049 |
88 | Corneal erosion (HP:0200020) | 2.00728723 |
89 | Vascular calcification (HP:0004934) | 2.00147988 |
90 | Hyperglycinuria (HP:0003108) | 1.99684105 |
91 | Asymmetry of the thorax (HP:0001555) | 1.99105310 |
92 | Fragile nails (HP:0001808) | 1.98443022 |
93 | Conjunctival hamartoma (HP:0100780) | 1.97956778 |
94 | Ulnar bowing (HP:0003031) | 1.97678001 |
95 | Ectropion (HP:0000656) | 1.97340639 |
96 | Dehydration (HP:0001944) | 1.97064538 |
97 | Erythroderma (HP:0001019) | 1.96973063 |
98 | Increased CSF protein (HP:0002922) | 1.96657794 |
99 | Hyperacusis (HP:0010780) | 1.96235583 |
100 | Alopecia of scalp (HP:0002293) | 1.95830545 |
101 | Cardiovascular calcification (HP:0011915) | 1.95827450 |
102 | Acanthosis nigricans (HP:0000956) | 1.95325703 |
103 | Cervical subluxation (HP:0003308) | 1.95270506 |
104 | Curly hair (HP:0002212) | 1.95165036 |
105 | Distal lower limb amyotrophy (HP:0008944) | 1.94160229 |
106 | Cubitus valgus (HP:0002967) | 1.91766773 |
107 | Glomerulosclerosis (HP:0000096) | 1.91697103 |
108 | Overgrowth (HP:0001548) | 1.90483488 |
109 | Autoimmune thrombocytopenia (HP:0001973) | 1.89914035 |
110 | Abnormality of the gastric mucosa (HP:0004295) | 1.89564816 |
111 | Peritonitis (HP:0002586) | 1.89561209 |
112 | Missing ribs (HP:0000921) | 1.88610547 |
113 | Prolonged partial thromboplastin time (HP:0003645) | 1.87845442 |
114 | Relative macrocephaly (HP:0004482) | 1.86759361 |
115 | Steatorrhea (HP:0002570) | 1.86708644 |
116 | Mitral stenosis (HP:0001718) | 1.86608114 |
117 | Mitral valve prolapse (HP:0001634) | 1.83125488 |
118 | Diaphragmatic weakness (HP:0009113) | 1.82933624 |
119 | Selective tooth agenesis (HP:0001592) | 1.82922882 |
120 | Erythema (HP:0010783) | 1.82238966 |
121 | Coarse hair (HP:0002208) | 1.82101732 |
122 | Advanced eruption of teeth (HP:0006288) | 1.81203304 |
123 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.80303303 |
124 | Ketosis (HP:0001946) | 1.80102273 |
125 | Hypolipoproteinemia (HP:0010981) | 1.80044297 |
126 | Hemorrhage of the eye (HP:0011885) | 1.80027464 |
127 | Neonatal short-limb short stature (HP:0008921) | 1.79884957 |
128 | Bladder diverticulum (HP:0000015) | 1.79571161 |
129 | Spinal rigidity (HP:0003306) | 1.79028713 |
130 | Aplasia cutis congenita (HP:0001057) | 1.78916004 |
131 | Abnormality of purine metabolism (HP:0004352) | 1.78852129 |
132 | Aneurysm (HP:0002617) | 1.78622308 |
133 | Hypoplasia of the iris (HP:0007676) | 1.78525458 |
134 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.78250893 |
135 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.78229364 |
136 | Tetraparesis (HP:0002273) | 1.77115671 |
137 | Interstitial pulmonary disease (HP:0006530) | 1.77080795 |
138 | Thin skin (HP:0000963) | 1.76008885 |
139 | Aplasia involving bones of the extremities (HP:0009825) | 1.75019263 |
140 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.75019263 |
141 | Aplasia of the phalanges of the hand (HP:0009802) | 1.75019263 |
142 | Follicular hyperkeratosis (HP:0007502) | 1.74944274 |
143 | Neurofibrillary tangles (HP:0002185) | 1.74382902 |
144 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.74063411 |
145 | Mitral regurgitation (HP:0001653) | 1.73574156 |
146 | Dilatation of the ascending aorta (HP:0005111) | 1.72969893 |
147 | Conjugated hyperbilirubinemia (HP:0002908) | 1.72389828 |
148 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.72386462 |
149 | Gingival bleeding (HP:0000225) | 1.72369396 |
150 | Recurrent abscess formation (HP:0002722) | 1.72364240 |
151 | Abnormality of the acetabulum (HP:0003170) | 1.71914359 |
152 | Urticaria (HP:0001025) | 1.71868227 |
153 | Thin bony cortex (HP:0002753) | 1.71459983 |
154 | Orchitis (HP:0100796) | 1.71213059 |
155 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.71160429 |
156 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.71159850 |
157 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.71036584 |
158 | Pruritus (HP:0000989) | 1.70618781 |
159 | Abnormality of glycine metabolism (HP:0010895) | 1.70019606 |
160 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.70019606 |
161 | Scanning speech (HP:0002168) | 1.69530993 |
162 | Turricephaly (HP:0000262) | 1.69183789 |
163 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.68985675 |
164 | Distal lower limb muscle weakness (HP:0009053) | 1.68544353 |
165 | Natal tooth (HP:0000695) | 1.68321392 |
166 | Soft skin (HP:0000977) | 1.68306292 |
167 | Deviation of the thumb (HP:0009603) | 1.67623483 |
168 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.66977994 |
169 | Abnormality of chloride homeostasis (HP:0011422) | 1.66787506 |
170 | Abnormal auditory evoked potentials (HP:0006958) | 1.65979934 |
171 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.65596556 |
172 | Cerebral inclusion bodies (HP:0100314) | 1.65369939 |
173 | Hypopigmentation of the fundus (HP:0007894) | 1.64165287 |
174 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.63984902 |
175 | Elbow flexion contracture (HP:0002987) | 1.63412281 |
176 | Viral hepatitis (HP:0006562) | 1.62531751 |
177 | Renal cell carcinoma (HP:0005584) | 1.61026971 |
178 | Pili torti (HP:0003777) | 1.60435681 |
179 | Abnormal ossification of hand bones (HP:0005921) | 1.57535359 |
180 | Dysmetric saccades (HP:0000641) | 1.54449616 |
181 | Shallow orbits (HP:0000586) | 1.53264195 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 3.68001790 |
2 | MST1R | 3.41136527 |
3 | EPHA2 | 3.18908559 |
4 | SCYL2 | 2.64851335 |
5 | LATS1 | 2.61947763 |
6 | STK39 | 2.61356979 |
7 | TRIB3 | 2.45320165 |
8 | TGFBR2 | 2.38180177 |
9 | RIPK1 | 2.20404681 |
10 | MAP3K14 | 2.04567466 |
11 | PTK6 | 1.99390045 |
12 | TBK1 | 1.99103689 |
13 | MAP3K3 | 1.95233396 |
14 | EPHB1 | 1.94591537 |
15 | LATS2 | 1.92632794 |
16 | ICK | 1.92001136 |
17 | FGFR4 | 1.90142984 |
18 | TYK2 | 1.88371087 |
19 | EEF2K | 1.86896280 |
20 | TAOK3 | 1.79657074 |
21 | MAP3K2 | 1.73376985 |
22 | SIK1 | 1.64590686 |
23 | ERBB3 | 1.63187599 |
24 | FRK | 1.59463542 |
25 | PBK | 1.50560598 |
26 | CAMK1D | 1.49697375 |
27 | JAK1 | 1.48857027 |
28 | PRPF4B | 1.45612532 |
29 | MET | 1.41365626 |
30 | MAPKAPK3 | 1.41081430 |
31 | IRAK3 | 1.40557251 |
32 | MAPK15 | 1.39465787 |
33 | BRD4 | 1.37822588 |
34 | BCKDK | 1.36528290 |
35 | PKN2 | 1.36057623 |
36 | AKT3 | 1.33849742 |
37 | BMX | 1.33440843 |
38 | INSRR | 1.32419050 |
39 | EPHA3 | 1.30517808 |
40 | FGFR3 | 1.28619570 |
41 | STK38L | 1.27044827 |
42 | FER | 1.24137178 |
43 | RIPK4 | 1.20808775 |
44 | MST4 | 1.20740938 |
45 | IKBKE | 1.20523082 |
46 | IKBKB | 1.17163459 |
47 | TTN | 1.14481402 |
48 | TRPM7 | 1.14217393 |
49 | PIK3CG | 1.11210565 |
50 | STK10 | 1.10684565 |
51 | JAK2 | 1.06988478 |
52 | MAP3K6 | 1.05500765 |
53 | PAK4 | 1.04725890 |
54 | PDGFRA | 1.04581898 |
55 | STK3 | 1.03011772 |
56 | PDGFRB | 0.97069000 |
57 | CDK6 | 0.95556243 |
58 | NEK9 | 0.95529702 |
59 | LRRK2 | 0.95423257 |
60 | CHUK | 0.93783847 |
61 | CAMK1G | 0.93092839 |
62 | NTRK1 | 0.92365010 |
63 | NEK6 | 0.92035333 |
64 | LMTK2 | 0.91583367 |
65 | MAP2K3 | 0.86462549 |
66 | EPHB2 | 0.84250358 |
67 | FGFR2 | 0.83628030 |
68 | JAK3 | 0.83287650 |
69 | PTK2 | 0.81969183 |
70 | MAP3K1 | 0.80734024 |
71 | MELK | 0.78646639 |
72 | CSK | 0.78190814 |
73 | GSK3A | 0.78055187 |
74 | PRKAA2 | 0.78026465 |
75 | DMPK | 0.76590381 |
76 | MAP3K7 | 0.73909016 |
77 | ERBB4 | 0.72750193 |
78 | DYRK1B | 0.71771076 |
79 | KIT | 0.71648062 |
80 | MAP2K2 | 0.71283662 |
81 | WNK4 | 0.69156584 |
82 | KSR1 | 0.66956904 |
83 | SGK3 | 0.66847661 |
84 | PNCK | 0.65398602 |
85 | BRSK2 | 0.65312901 |
86 | YES1 | 0.63853135 |
87 | STK38 | 0.63103566 |
88 | RET | 0.63039238 |
89 | ITK | 0.62859003 |
90 | ZAP70 | 0.60964210 |
91 | MAP2K1 | 0.59512429 |
92 | PRKD1 | 0.59247535 |
93 | FGFR1 | 0.56738426 |
94 | HCK | 0.56730337 |
95 | ABL1 | 0.56540666 |
96 | AKT2 | 0.55971418 |
97 | ROCK2 | 0.53840164 |
98 | EIF2AK3 | 0.53600295 |
99 | PAK2 | 0.52450414 |
100 | MAP3K12 | 0.51902365 |
101 | PDPK1 | 0.51155658 |
102 | MAP4K1 | 0.50788383 |
103 | EIF2AK1 | 0.50429804 |
104 | FLT3 | 0.50071990 |
105 | MAP3K13 | 0.49394369 |
106 | IGF1R | 0.49145279 |
107 | MAPK11 | 0.48959229 |
108 | DDR2 | 0.48257625 |
109 | PRKD3 | 0.48037003 |
110 | IRAK1 | 0.47235244 |
111 | BCR | 0.47213004 |
112 | MOS | 0.46965003 |
113 | KSR2 | 0.45874907 |
114 | BLK | 0.45090646 |
115 | SIK3 | 0.44855791 |
116 | BMPR2 | 0.44657316 |
117 | EGFR | 0.44647317 |
118 | TIE1 | 0.44401641 |
119 | ERBB2 | 0.44281100 |
120 | PIK3CA | 0.44249353 |
121 | HIPK2 | 0.43274039 |
122 | SMG1 | 0.42855280 |
123 | MAPKAPK2 | 0.42232297 |
124 | MYLK | 0.41975711 |
125 | RPS6KB2 | 0.41283105 |
126 | ABL2 | 0.41221834 |
127 | PRKCH | 0.41090657 |
128 | STK24 | 0.41019270 |
129 | CDK8 | 0.40748177 |
130 | WEE1 | 0.40740195 |
131 | MAP3K8 | 0.40201543 |
132 | WNK1 | 0.39969637 |
133 | TGFBR1 | 0.39692170 |
134 | CDK12 | 0.38570002 |
135 | EIF2AK2 | 0.38440845 |
136 | CDK9 | 0.37677882 |
137 | PRKG2 | 0.37012672 |
138 | CSF1R | 0.36686488 |
139 | MTOR | 0.36315426 |
140 | NEK2 | 0.32224803 |
141 | RPS6KB1 | 0.32072176 |
142 | PRKD2 | 0.30246119 |
143 | ROCK1 | 0.29371443 |
144 | MAPK10 | 0.27382074 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.73563645 |
2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.22560808 |
3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.15748888 |
4 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.00408556 |
5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.98844367 |
6 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.95604556 |
7 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.91564540 |
8 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.86391638 |
9 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.86210802 |
10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.81829681 |
11 | Thyroid cancer_Homo sapiens_hsa05216 | 1.81781747 |
12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.68532490 |
13 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.64689920 |
14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.55986617 |
15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.51267627 |
16 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.51141367 |
17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.49364313 |
18 | ABC transporters_Homo sapiens_hsa02010 | 1.47918971 |
19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.42594212 |
20 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.42016418 |
21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.41497971 |
22 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.40415421 |
23 | Endometrial cancer_Homo sapiens_hsa05213 | 1.39917009 |
24 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.38805892 |
25 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.37097643 |
26 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.34889444 |
27 | Bile secretion_Homo sapiens_hsa04976 | 1.33350028 |
28 | Bladder cancer_Homo sapiens_hsa05219 | 1.27698547 |
29 | Glioma_Homo sapiens_hsa05214 | 1.27455408 |
30 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.26736395 |
31 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.25632625 |
32 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.25226258 |
33 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.23988326 |
34 | Lysosome_Homo sapiens_hsa04142 | 1.23493023 |
35 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.22988023 |
36 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.22043776 |
37 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.19650560 |
38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.18958736 |
39 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.18598955 |
40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.18388217 |
41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.17128623 |
42 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.15478111 |
43 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.14537114 |
44 | Prostate cancer_Homo sapiens_hsa05215 | 1.12482472 |
45 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.11946664 |
46 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.11509522 |
47 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.08502141 |
48 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.08022049 |
49 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.07469383 |
50 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.06846962 |
51 | Leishmaniasis_Homo sapiens_hsa05140 | 1.06117047 |
52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.06031117 |
53 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.05750482 |
54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.05708106 |
55 | Melanogenesis_Homo sapiens_hsa04916 | 1.05536247 |
56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.05487329 |
57 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.03852542 |
58 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.03133770 |
59 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.02991723 |
60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.01452363 |
61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.01035545 |
62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.00731771 |
63 | Retinol metabolism_Homo sapiens_hsa00830 | 1.00164727 |
64 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.99959158 |
65 | Prion diseases_Homo sapiens_hsa05020 | 0.99385984 |
66 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.98881035 |
67 | Pathways in cancer_Homo sapiens_hsa05200 | 0.98568470 |
68 | Peroxisome_Homo sapiens_hsa04146 | 0.97197321 |
69 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.97000022 |
70 | Other glycan degradation_Homo sapiens_hsa00511 | 0.96778717 |
71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.96759860 |
72 | Insulin resistance_Homo sapiens_hsa04931 | 0.95771721 |
73 | Amoebiasis_Homo sapiens_hsa05146 | 0.93241150 |
74 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.91545632 |
75 | Circadian rhythm_Homo sapiens_hsa04710 | 0.90832772 |
76 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.90628744 |
77 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.90149169 |
78 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.89910051 |
79 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.89620160 |
80 | Endocytosis_Homo sapiens_hsa04144 | 0.89186193 |
81 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.88756966 |
82 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.87246690 |
83 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.86161025 |
84 | Pertussis_Homo sapiens_hsa05133 | 0.84434459 |
85 | Mineral absorption_Homo sapiens_hsa04978 | 0.84205156 |
86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.83621538 |
87 | Tight junction_Homo sapiens_hsa04530 | 0.83267141 |
88 | Long-term potentiation_Homo sapiens_hsa04720 | 0.82790329 |
89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.82624607 |
90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.81354238 |
91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.81353827 |
92 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.81029055 |
93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.79873398 |
94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.79280534 |
95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79008642 |
96 | Gap junction_Homo sapiens_hsa04540 | 0.78452223 |
97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.77951584 |
98 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.77864411 |
99 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77858982 |
100 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.77755109 |
101 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.77439497 |
102 | Melanoma_Homo sapiens_hsa05218 | 0.77163523 |
103 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.75023803 |
104 | Malaria_Homo sapiens_hsa05144 | 0.74593096 |
105 | Shigellosis_Homo sapiens_hsa05131 | 0.74318935 |
106 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.73171422 |
107 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.73162366 |
108 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.72859994 |
109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72416098 |
110 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.72233716 |
111 | Adherens junction_Homo sapiens_hsa04520 | 0.72137095 |
112 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.72119133 |
113 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.71418993 |
114 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.71186219 |
115 | Hepatitis C_Homo sapiens_hsa05160 | 0.70578302 |
116 | Tuberculosis_Homo sapiens_hsa05152 | 0.70036570 |
117 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.69113753 |
118 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.68957307 |
119 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.68523887 |
120 | Lysine degradation_Homo sapiens_hsa00310 | 0.68486612 |
121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68262593 |
122 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.67155029 |
123 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.63915853 |
124 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.63608544 |
125 | Hepatitis B_Homo sapiens_hsa05161 | 0.63019108 |
126 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62853640 |
127 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.61540749 |
128 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60997298 |
129 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60497301 |
130 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.60143840 |
131 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58189943 |
132 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.57794596 |
133 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57658693 |
134 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.57058478 |
135 | Influenza A_Homo sapiens_hsa05164 | 0.56637357 |
136 | Legionellosis_Homo sapiens_hsa05134 | 0.56302690 |
137 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.55970906 |
138 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.55610083 |
139 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55254330 |
140 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55177205 |
141 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.55165872 |
142 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.54298317 |
143 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.53791319 |
144 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.53611326 |
145 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.53466988 |
146 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.52751811 |
147 | Axon guidance_Homo sapiens_hsa04360 | 0.52085955 |
148 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51788808 |
149 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.51642420 |
150 | Salmonella infection_Homo sapiens_hsa05132 | 0.50195622 |
151 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50063015 |
152 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49513904 |
153 | Focal adhesion_Homo sapiens_hsa04510 | 0.48710072 |
154 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48604445 |
155 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.47419463 |
156 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.46592371 |
157 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.46412688 |
158 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.43042049 |
159 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42567393 |
160 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41347856 |
161 | Apoptosis_Homo sapiens_hsa04210 | 0.41048895 |
162 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39382471 |
163 | Platelet activation_Homo sapiens_hsa04611 | 0.38414406 |
164 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.38070558 |
165 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38043736 |
166 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.37887323 |
167 | Measles_Homo sapiens_hsa05162 | 0.37511715 |